Interleukin Genetics Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 7

  • Investments
  • 1

Interleukin Genetics General Information

Description

Developer of genetic testing technology designed to adhere the needs of chronic diseases and health-related conditions. The company's genetic testing technology includes brand of genetic tests that offer clear and personalized insights to wellness and includes personalized guidance on specific diet and exercise choices, enabling patients to improve their health outcomes.

Contact Information

Formerly Known As
Medical Science Systems, Medical Science Systems Inc
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 135 Beaver Street
  • Waltham, MA 02452
  • United States
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 135 Beaver Street
  • Waltham, MA 02452
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Interleukin Genetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Interleukin Genetics‘s full profile, request access.

Request a free trial

Interleukin Genetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genetic testing technology designed to adhere the needs of chronic diseases and health-related conditions.
Laboratory Services (Healthcare)
Waltham, MA
14 As of 2016

San Diego, CA
 

Newcastle Upon Tyne, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Interleukin Genetics Competitors (3)

One of Interleukin Genetics’s 3 competitors is Element Biosciences, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Element Biosciences Venture Capital-Backed San Diego, CA
QuantuMDx Venture Capital-Backed Newcastle Upon Tyne, United Kingdom
Llusern Scientific Venture Capital-Backed Cardiff, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Interleukin Genetics Patents

Interleukin Genetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018130670-A1 Methods and kits for treating cardiovascular disease Inactive 12-Jan-2017
AU-2017207341-A1 Methods for predicting response to treatment Inactive 12-Jan-2016
CA-3011363-A1 Methods for predicting response to treatment Pending 12-Jan-2016
WO-2017123696-A1 Methods for predicting response to treatment Inactive 12-Jan-2016
JP-2017121237-A Improved method and kit for determining severity and progression of periodontal disease Active 09-Dec-2010 C12Q1/6883
To view Interleukin Genetics’s complete patent history, request access »

Interleukin Genetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Interleukin Genetics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Interleukin Genetics‘s full profile, request access.

Request a free trial

Interleukin Genetics Acquisitions (1)

Interleukin Genetics’s most recent deal was a Merger/Acquisition with Alan James Group. The deal was made on 01-Sep-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alan James Group 01-Sep-2006 Merger/Acquisition Drug Delivery
To view Interleukin Genetics’s complete acquisitions history, request access »

Interleukin Genetics Exits (1)

Interleukin Genetics’s most recent exit was on 01-Sep-2006 from Alan James Group. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Alan James Group 01-Sep-2006 Completed
To view Interleukin Genetics’s complete exits history, request access »

Interleukin Genetics FAQs

  • When was Interleukin Genetics founded?

    Interleukin Genetics was founded in 1986.

  • Where is Interleukin Genetics headquartered?

    Interleukin Genetics is headquartered in Waltham, MA.

  • What is the size of Interleukin Genetics?

    Interleukin Genetics has 14 total employees.

  • What industry is Interleukin Genetics in?

    Interleukin Genetics’s primary industry is Laboratory Services (Healthcare).

  • Is Interleukin Genetics a private or public company?

    Interleukin Genetics is a Private company.

  • What is Interleukin Genetics’s current revenue?

    The current revenue for Interleukin Genetics is .

  • How much funding has Interleukin Genetics raised over time?

    Interleukin Genetics has raised $45.8M.

  • Who are Interleukin Genetics’s investors?

    Bay City Capital, New Enterprise Associates, Nexus Life Science Partners, and Pyxis Innovations have invested in Interleukin Genetics.

  • Who are Interleukin Genetics’s competitors?

    Element Biosciences, QuantuMDx, and Llusern Scientific are competitors of Interleukin Genetics.

  • When was Interleukin Genetics acquired?

    Interleukin Genetics was acquired on 22-Nov-2017.

  • Who acquired Interleukin Genetics?

    Interleukin Genetics was acquired by Seaport Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process